These results are consistent with previous findings, where HRG have been demonstrated to have a concentration-dependent, biphasic stimulatory/anti-proliferative effect on HER2-overexpressing breast cancer cell lines [29], [30], [31]. This evidence concerns the gene ERBB2 and breast carcinoma.